Tainsky MA - Search Results

1

DNA Repair Mechanisms, Protein Interactions and Therapeutic Targeting of the MRN Complex.

McCarthy-Leo C, Darwiche F, Tainsky MA. McCarthy-Leo C, et al. Among authors: tainsky ma. Cancers (Basel). 2022 Oct 27;14(21):5278. doi: 10.3390/cancers14215278. Cancers (Basel). 2022. PMID: 36358700 Free PMC article. Review.

2

Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability.

Baughan SL, Darwiche F, Tainsky MA. Baughan SL, et al. Among authors: tainsky ma. Cancer Genet. 2022 Jun;264-265:40-49. doi: 10.1016/j.cancergen.2022.03.003. Epub 2022 Mar 20. Cancer Genet. 2022. PMID: 35354106 Free article.

3

K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review.

Baughan S, Tainsky MA. Baughan S, et al. Among authors: tainsky ma. Cancers (Basel). 2021 Jan 25;13(3):447. doi: 10.3390/cancers13030447. Cancers (Basel). 2021. PMID: 33503928 Free PMC article. Review.

4

Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a TP53I3 (PIG3) variant in ROS production and DNA repair.

Chaudhry SR, Lopes J, Levin NK, Kalpage H, Tainsky MA. Chaudhry SR, et al. Among authors: tainsky ma. Cell Death Discov. 2021 Mar 29;7(1):62. doi: 10.1038/s41420-021-00442-y. Cell Death Discov. 2021. PMID: 33782397 Free PMC article.

5

Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.

Stafford JL, Dyson G, Levin NK, Chaudhry S, Rosati R, Kalpage H, Wernette C, Petrucelli N, Simon MS, Tainsky MA. Stafford JL, et al. Among authors: tainsky ma. PLoS One. 2017 Jun 7;12(6):e0178450. doi: 10.1371/journal.pone.0178450. eCollection 2017. PLoS One. 2017. PMID: 28591191 Free PMC article.

6

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.

Kaplun L, Fridman AL, Chen W, Levin NK, Ahsan S, Petrucelli N, Barrick JL, Gold R, Land S, Simon MS, Morris RT, Munkarah AR, Tainsky MA. Kaplun L, et al. Among authors: tainsky ma. Biomark Insights. 2012;7:151-7. doi: 10.4137/BMI.S10815. Epub 2012 Dec 12. Biomark Insights. 2012. PMID: 23300341 Free PMC article.

7

FANCM, RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer.

Lopes JL, Chaudhry S, Lopes GS, Levin NK, Tainsky MA. Lopes JL, et al. Among authors: tainsky ma. Cancer Genet. 2019 Jun;235-236:57-64. doi: 10.1016/j.cancergen.2019.04.061. Epub 2019 May 9. Cancer Genet. 2019. PMID: 31078449

8

Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.

Ahsan S, Ge Y, Tainsky MA. Ahsan S, et al. Among authors: tainsky ma. Oncotarget. 2016 Aug 30;7(35):57171-57185. doi: 10.18632/oncotarget.11036. Oncotarget. 2016. PMID: 27494873 Free PMC article.

9

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.

Chatterjee M, Hurley LC, Tainsky MA. Chatterjee M, et al. Among authors: tainsky ma. Gynecol Oncol Rep. 2017 Jun 15;21:37-44. doi: 10.1016/j.gore.2017.06.006. eCollection 2017 Aug. Gynecol Oncol Rep. 2017. PMID: 28653032 Free PMC article. Review.

10

Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.

Wang X, Teer JK, Tousignant RN, Levin AM, Boulware D, Chitale DA, Shaw BM, Chen Z, Zhang Y, Blakeley JO, Acosta MT, Messiaen LM, Korf BR, Tainsky MA. Wang X, et al. Among authors: tainsky ma. Genes Chromosomes Cancer. 2018 Jan;57(1):19-27. doi: 10.1002/gcc.22503. Epub 2017 Sep 30. Genes Chromosomes Cancer. 2018. PMID: 28891274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page